1. Variants within the SP110 nuclear body protein modify risk of canine degenerative myelopathy
- Author
-
Martin L. Katz, Gary S. Johnson, Izabella Baranowska Körberg, Eva Murén, Joan R. Coates, Michele Koltookian, Gayle C. Johnson, Kate Megquier, Kerstin Lindblad-Toh, A. Kolicheski, Noriko Tonomura, Sergey V. Kozyrev, Rong Zeng, Liz Hansen, Emma L. Ivansson, and Ross Swofford
- Subjects
0301 basic medicine ,SP110 nuclear body protein ,Male ,Pathology ,medicine.medical_specialty ,SOD1 ,Genome-wide association study ,Disease ,Biology ,Canine degenerative myelopathy ,Real-Time Polymerase Chain Reaction ,Spinal Cord Diseases ,03 medical and health sciences ,Dogs ,Muscular Diseases ,medicine ,Animals ,Dog Diseases ,RNA, Messenger ,Nuclear protein ,Amyotrophic lateral sclerosis ,Age of Onset ,Multidisciplinary ,Reverse Transcriptase Polymerase Chain Reaction ,Superoxide Dismutase ,Homozygote ,Nuclear Proteins ,Neurodegenerative Diseases ,medicine.disease ,Disease Models, Animal ,030104 developmental biology ,PNAS Plus ,Mutation ,Female ,Age of onset ,Genome-Wide Association Study - Abstract
Canine degenerative myelopathy (DM) is a naturally occurring neurodegenerative disease with similarities to some forms of amyotrophic lateral sclerosis (ALS). Most dogs that develop DM are homozygous for a common superoxide dismutase 1 gene (SOD1) mutation. However, not all dogs homozygous for this mutation develop disease. We performed a genome-wide association analysis in the Pembroke Welsh Corgi (PWC) breed comparing DM-affected and -unaffected dogs homozygous for the SOD1 mutation. The analysis revealed a modifier locus on canine chromosome 25. A haplotype within the SP110 nuclear body protein (SP110) was present in 40% of affected compared with 4% of unaffected dogs (P = 1.5 × 10(-5)), and was associated with increased probability of developing DM (P = 4.8 × 10(-6)) and earlier onset of disease (P = 1.7 × 10(-5)). SP110 is a nuclear body protein involved in the regulation of gene transcription. Our findings suggest that variations in SP110-mediated gene transcription may underlie, at least in part, the variability in risk for developing DM among PWCs that are homozygous for the disease-related SOD1 mutation. Further studies are warranted to clarify the effect of this modifier across dog breeds.
- Published
- 2016